{"organizations": [], "uuid": "253c6000ddf808956483aa956f881e5703a64f27", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180227.html", "section_title": "Archive News &amp; Video for Tuesday, 27 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-quentis-therapeutics-debuts-with-4/brief-quentis-therapeutics-debuts-with-48-mln-series-a-financing-idUSASB0C7OH", "country": "US", "domain_rank": 408, "title": "BRIEF-Quentis Therapeutics Debuts With $48 Mln Series A Financing", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.364, "site_type": "news", "published": "2018-02-27T20:49:00.000+02:00", "replies_count": 0, "uuid": "253c6000ddf808956483aa956f881e5703a64f27"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-quentis-therapeutics-debuts-with-4/brief-quentis-therapeutics-debuts-with-48-mln-series-a-financing-idUSASB0C7OH", "ord_in_thread": 0, "title": "BRIEF-Quentis Therapeutics Debuts With $48 Mln Series A Financing", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "versant ventures", "sentiment": "none"}, {"name": "polaris", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 27 (Reuters) - Quentis Therapeutics:\n* QUENTIS THERAPEUTICS DEBUTS WITH $48 MILLION SERIES A FINANCING TO ADVANCE FIRST-IN-CLASS IMMUNOTHERAPIES TARGETING ENDOPLASMIC RETICULUM STRESS RESPONSE PATHWAYS\n* QUENTIS THERAPEUTICS ​- ‍SERIES A FINANCING CO-LED BY VERSANT VENTURES, POLARIS PARTNERS, AFFILIATED LS POLARIS INNOVATION FUND Source text for Eikon:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-27T20:49:00.000+02:00", "crawled": "2018-02-28T12:53:33.007+02:00", "highlightTitle": ""}